Last edition
News about "Active Pharmaceutical Ingredients "
Pharma Industry's Wishlist for Budget 2025: Key Expectations
The forthcoming Union Budget 2025 presents a pivotal opportunity for the Indian pharmaceutical sector to address existing challenges and pave the way for sustainable growth.
Active Pharmaceutical Ingredients | 22/01/2025 | By Aishwarya | 199
Glenmark Life Sciences Rebrands its Identity as Alivus Life Sciences
The new identity, Alivus Life Sciences, represents vitality and growth with a renewed focus.
Active Pharmaceutical Ingredients | 20/01/2025 | By Aishwarya | 206
Agilent Announces Acquisition of BIOVECTRA
With the addition of BIOVECTRA, Agilent will expand its portfolio of CDMO services, add rapidly growing modalities, and bring world-class capabilities to support gene editing.
Active Pharmaceutical Ingredients | 24/09/2024 | By Aishwarya | 197
Lonza Inaugurates Innovaform Accelerator CoE in France
The new Innovaform Accelerator will serve as a Center of Excellence (CoE) for developing and innovating capsule-based manufacturing and delivery solutions for oral and pulmonary administration.
Active Pharmaceutical Ingredients | 20/09/2024 | By Aishwarya | 104
Nusano and PharmaLogic to Offer Current and Emerging Radiopharmaceuticals
Nusano Inc. has inked a supply agreement with PharmaLogic to provide a more efficient and reliable supply of critical radioisotopes.
Active Pharmaceutical Ingredients | 11/07/2024 | By Aishwarya
Lupin Names Abdelaziz Toumi as CEO of its Subsidiary
Lupin has appointed Abdelaziz Toumi (Abdel) as the Chief Executive Officer of its newly formed subsidiary, Lupin Manufacturing Solutions (LMS).
Active Pharmaceutical Ingredients | 18/06/2024 | By Aishwarya | 179
Torrent Pharmaceuticals Receives EIR from USFDA for Dahej Facility
The Dahej facility was placed under OAI by the USFDA based on the March 2019 Inspection outcome.
Active Pharmaceutical Ingredients | 25/08/2023 | By Manvi | 736
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy